Ostabolin (Zelos)
- Generic Name
- Ostabolin (Zelos)
A Proof-of-Concept Study Investigating the Safety and Efficacy of ZT-031 on Hip Fracture Healing in Men and Postmenopausal Women
- First Posted Date
- 2008-11-07
- Last Posted Date
- 2009-06-04
- Lead Sponsor
- Zelos Therapeutics
- Target Recruit Count
- 50
- Registration Number
- NCT00787358
- Locations
- 🇺🇸
J. Edward Puzas, Rochester, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath